

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.52985084 |
| 2 | negative T cell selection (GO:0043383) | 7.29273337 |
| 3 | positive T cell selection (GO:0043368) | 6.98504553 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.71299272 |
| 5 | positive thymic T cell selection (GO:0045059) | 6.71260237 |
| 6 | negative thymic T cell selection (GO:0045060) | 6.69309562 |
| 7 | negative regulation of cell killing (GO:0031342) | 6.53446854 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.53446854 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 6.52853668 |
| 10 | T cell selection (GO:0045058) | 6.19003681 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 6.17762176 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.16928369 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.16928369 |
| 14 | interferon-gamma production (GO:0032609) | 6.10103319 |
| 15 | thymic T cell selection (GO:0045061) | 6.04274331 |
| 16 | response to interleukin-15 (GO:0070672) | 5.77144643 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.72815634 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.66722657 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.51897594 |
| 20 | T cell migration (GO:0072678) | 5.28062423 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 5.18750357 |
| 22 | thrombin receptor signaling pathway (GO:0070493) | 5.12274692 |
| 23 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.03602461 |
| 24 | regulation of platelet aggregation (GO:0090330) | 4.93181315 |
| 25 | * T cell receptor signaling pathway (GO:0050852) | 4.86552553 |
| 26 | leukocyte aggregation (GO:0070486) | 4.58293888 |
| 27 | activated T cell proliferation (GO:0050798) | 4.57334774 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.52887291 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 4.48741987 |
| 30 | neutrophil activation (GO:0042119) | 4.48283300 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 4.40194735 |
| 32 | positive regulation of interleukin-2 production (GO:0032743) | 4.37942486 |
| 33 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.31062516 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 4.29537504 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28565390 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.26121169 |
| 37 | * T cell costimulation (GO:0031295) | 4.20924017 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.18188337 |
| 39 | * lymphocyte costimulation (GO:0031294) | 4.13253321 |
| 40 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.03338975 |
| 41 | granulocyte activation (GO:0036230) | 4.01045576 |
| 42 | megakaryocyte development (GO:0035855) | 3.98849947 |
| 43 | regulation of platelet activation (GO:0010543) | 3.96460990 |
| 44 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.94117095 |
| 45 | V(D)J recombination (GO:0033151) | 3.91936484 |
| 46 | positive regulation of isotype switching (GO:0045830) | 3.90708971 |
| 47 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.89354172 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.88947328 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.82595812 |
| 50 | alpha-beta T cell activation (GO:0046631) | 3.80894399 |
| 51 | positive regulation of macrophage differentiation (GO:0045651) | 3.79314782 |
| 52 | platelet aggregation (GO:0070527) | 3.78114467 |
| 53 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.76065601 |
| 54 | tolerance induction (GO:0002507) | 3.74205660 |
| 55 | leukocyte degranulation (GO:0043299) | 3.73576300 |
| 56 | alpha-beta T cell differentiation (GO:0046632) | 3.72467772 |
| 57 | positive regulation of tolerance induction (GO:0002645) | 3.65977496 |
| 58 | T cell homeostasis (GO:0043029) | 3.65566429 |
| 59 | T cell differentiation (GO:0030217) | 3.63416256 |
| 60 | protein neddylation (GO:0045116) | 3.62440688 |
| 61 | negative regulation of T cell apoptotic process (GO:0070233) | 3.61880437 |
| 62 | regulation of B cell differentiation (GO:0045577) | 3.58621178 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.57263778 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.54444057 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52731343 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48749995 |
| 67 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47020865 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 3.47020865 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47020865 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47020865 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47020865 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 3.47020865 |
| 73 | mast cell activation (GO:0045576) | 3.43323570 |
| 74 | angiogenesis involved in wound healing (GO:0060055) | 3.41086959 |
| 75 | positive regulation of DNA recombination (GO:0045911) | 3.40356726 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.39945508 |
| 77 | regulation of isotype switching (GO:0045191) | 3.38710286 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.38057056 |
| 79 | lymphocyte homeostasis (GO:0002260) | 3.36353264 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 3.35997567 |
| 81 | adenosine receptor signaling pathway (GO:0001973) | 3.33995849 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.30841125 |
| 83 | regulation of interleukin-2 production (GO:0032663) | 3.30346236 |
| 84 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.28227107 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.28227107 |
| 86 | natural killer cell activation (GO:0030101) | 3.26779325 |
| 87 | regulation of mast cell degranulation (GO:0043304) | 3.26067999 |
| 88 | mast cell activation involved in immune response (GO:0002279) | 3.24787045 |
| 89 | mast cell degranulation (GO:0043303) | 3.24787045 |
| 90 | regulation of mast cell activation (GO:0033003) | 3.23427669 |
| 91 | cellular extravasation (GO:0045123) | 3.21906903 |
| 92 | positive regulation of B cell mediated immunity (GO:0002714) | 3.20239695 |
| 93 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.20239695 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20108604 |
| 95 | positive regulation of granulocyte differentiation (GO:0030854) | 3.18497913 |
| 96 | regulation of response to interferon-gamma (GO:0060330) | 3.18000983 |
| 97 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17248305 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 3.16704337 |
| 99 | natural killer cell differentiation (GO:0001779) | 3.16691311 |
| 100 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.16356271 |
| 101 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.16282161 |
| 102 | positive regulation of humoral immune response (GO:0002922) | 3.15814258 |
| 103 | dendritic cell chemotaxis (GO:0002407) | 3.14524490 |
| 104 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.12841529 |
| 105 | lipoxygenase pathway (GO:0019372) | 3.11292590 |
| 106 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.11237403 |
| 107 | T cell activation (GO:0042110) | 3.10984185 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10972940 |
| 109 | microglial cell activation (GO:0001774) | 3.10347033 |
| 110 | blood coagulation, intrinsic pathway (GO:0007597) | 3.07939964 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.06263003 |
| 112 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05675964 |
| 113 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.05675964 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05601736 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.05447973 |
| 116 | T cell proliferation (GO:0042098) | 3.05424937 |
| 117 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.05409104 |
| 118 | homotypic cell-cell adhesion (GO:0034109) | 3.04929449 |
| 119 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.04520355 |
| 120 | detection of other organism (GO:0098543) | 3.04351001 |
| 121 | platelet formation (GO:0030220) | 3.04031486 |
| 122 | positive regulation of immunoglobulin production (GO:0002639) | 3.02492082 |
| 123 | detection of bacterium (GO:0016045) | 3.01465874 |
| 124 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.01308292 |
| 125 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00128188 |
| 126 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.99467656 |
| 127 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.97632118 |
| 128 | dendritic cell migration (GO:0036336) | 2.96621464 |
| 129 | positive regulation of B cell differentiation (GO:0045579) | 2.96457547 |
| 130 | regulation of granulocyte differentiation (GO:0030852) | 2.95939312 |
| 131 | hepatocyte apoptotic process (GO:0097284) | 2.93732048 |
| 132 | regulation of B cell mediated immunity (GO:0002712) | 2.93318416 |
| 133 | regulation of immunoglobulin production (GO:0002637) | 2.89075697 |
| 134 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.89045141 |
| 135 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.89045141 |
| 136 | B cell proliferation (GO:0042100) | 2.89002078 |
| 137 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.88685708 |
| 138 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.86600607 |
| 139 | lymphocyte migration (GO:0072676) | 2.84293427 |
| 140 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.84206856 |
| 141 | positive regulation of histone deacetylation (GO:0031065) | 2.84102427 |
| 142 | leukocyte homeostasis (GO:0001776) | 2.83951405 |
| 143 | actin nucleation (GO:0045010) | 2.83603024 |
| 144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81458782 |
| 145 | modulation by virus of host process (GO:0019054) | 2.80033954 |
| 146 | negative regulation of stress fiber assembly (GO:0051497) | 2.79796503 |
| 147 | T-helper cell differentiation (GO:0042093) | 2.79268605 |
| 148 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.79268605 |
| 149 | positive regulation of T cell differentiation (GO:0045582) | 2.78340828 |
| 150 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77424038 |
| 151 | positive regulation of mast cell degranulation (GO:0043306) | 2.77424038 |
| 152 | * positive regulation of T cell activation (GO:0050870) | 2.75583247 |
| 153 | lymphocyte differentiation (GO:0030098) | 2.74215700 |
| 154 | lymph node development (GO:0048535) | 2.73156916 |
| 155 | myeloid dendritic cell activation (GO:0001773) | 2.72874418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.21169408 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.78871184 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.80761118 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.25868501 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86625230 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.70884828 |
| 7 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.70738129 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.49344962 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.40531284 |
| 10 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.27961264 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.27769517 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13855087 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05376988 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.98087418 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.93504616 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93193013 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.79087712 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78053508 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.77436318 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67061995 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45779791 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.35653514 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.30524357 |
| 24 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.28141572 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21134948 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08698255 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08317550 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05168534 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 2.04436228 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04413181 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04184430 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01754952 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01208728 |
| 34 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00537990 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99194127 |
| 36 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94571386 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.93018431 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92222785 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92202320 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89474520 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89424236 |
| 42 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87512370 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87091713 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72722699 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70092747 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68211769 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65087743 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63144204 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61837138 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52479623 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46886486 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44455281 |
| 53 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44192925 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41688044 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.37493246 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35940465 |
| 57 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35400945 |
| 58 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32573495 |
| 59 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.31398828 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29749770 |
| 61 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.29448622 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28591831 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22863995 |
| 64 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20822614 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18222430 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16951137 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16359236 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15877609 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14119686 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14063618 |
| 71 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.14058849 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13654442 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10358137 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10205522 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08986021 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08939408 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08572411 |
| 78 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08507774 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08467465 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06830964 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06736899 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06501935 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04023547 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01496990 |
| 85 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01496837 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00457708 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00003328 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99600786 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98853039 |
| 90 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98476891 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97131075 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96433954 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95929831 |
| 94 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90467169 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85144706 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84338415 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84213135 |
| 98 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.83770612 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.83294282 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82852105 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82676967 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80343702 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79952389 |
| 104 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.79516060 |
| 105 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78987580 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76520452 |
| 107 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.75760701 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75020974 |
| 109 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75009306 |
| 110 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74767652 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74204080 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73312317 |
| 113 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72702769 |
| 114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72695604 |
| 115 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.72623118 |
| 116 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.71972906 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 0.71861809 |
| 118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71537923 |
| 119 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69860666 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.69020613 |
| 121 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68818943 |
| 122 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.68290528 |
| 123 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66991280 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66393858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.42688598 |
| 2 | MP0005671_abnormal_response_to | 3.99650756 |
| 3 | MP0000685_abnormal_immune_system | 3.71247918 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.53542630 |
| 5 | MP0001800_abnormal_humoral_immune | 3.43635539 |
| 6 | MP0005387_immune_system_phenotype | 3.35873786 |
| 7 | MP0001790_abnormal_immune_system | 3.35873786 |
| 8 | MP0008004_abnormal_stomach_pH | 3.27173384 |
| 9 | * MP0002398_abnormal_bone_marrow | 2.99968898 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.85499372 |
| 11 | MP0001819_abnormal_immune_cell | 2.81037311 |
| 12 | * MP0000703_abnormal_thymus_morphology | 2.79639149 |
| 13 | MP0002723_abnormal_immune_serum | 2.79273520 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.77352877 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.72192063 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.69858090 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.67367674 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.60320881 |
| 19 | * MP0000716_abnormal_immune_system | 2.52734842 |
| 20 | MP0002722_abnormal_immune_system | 2.44962499 |
| 21 | MP0001873_stomach_inflammation | 2.44569975 |
| 22 | MP0002405_respiratory_system_inflammati | 2.43207266 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.42590883 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.38334558 |
| 25 | MP0005025_abnormal_response_to | 2.23182671 |
| 26 | MP0002006_tumorigenesis | 2.23121736 |
| 27 | MP0009785_altered_susceptibility_to | 2.21220699 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.20618289 |
| 29 | MP0003436_decreased_susceptibility_to | 2.19900683 |
| 30 | * MP0002429_abnormal_blood_cell | 2.09893412 |
| 31 | MP0003303_peritoneal_inflammation | 2.05646569 |
| 32 | MP0003866_abnormal_defecation | 2.04075672 |
| 33 | MP0004947_skin_inflammation | 1.96311350 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.91080873 |
| 35 | MP0005083_abnormal_biliary_tract | 1.90757499 |
| 36 | MP0002419_abnormal_innate_immunity | 1.80760501 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.78000962 |
| 38 | MP0006082_CNS_inflammation | 1.75440241 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.74808987 |
| 40 | MP0002132_abnormal_respiratory_system | 1.69438326 |
| 41 | MP0004510_myositis | 1.67138032 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.64990736 |
| 43 | MP0003828_pulmonary_edema | 1.55779412 |
| 44 | MP0005310_abnormal_salivary_gland | 1.49105480 |
| 45 | MP0008057_abnormal_DNA_replication | 1.47304931 |
| 46 | MP0002933_joint_inflammation | 1.47077415 |
| 47 | MP0001853_heart_inflammation | 1.45627670 |
| 48 | MP0009278_abnormal_bone_marrow | 1.41290687 |
| 49 | MP0000490_abnormal_crypts_of | 1.40119495 |
| 50 | MP0004381_abnormal_hair_follicle | 1.39026303 |
| 51 | MP0000343_altered_response_to | 1.38267041 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.37967328 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.37967328 |
| 54 | MP0002009_preneoplasia | 1.33720333 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.33163059 |
| 56 | MP0000858_altered_metastatic_potential | 1.30404989 |
| 57 | MP0008260_abnormal_autophagy | 1.27330818 |
| 58 | MP0003724_increased_susceptibility_to | 1.27042327 |
| 59 | MP0004130_abnormal_muscle_cell | 1.25516029 |
| 60 | MP0003077_abnormal_cell_cycle | 1.16496820 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.15535147 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.14137433 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.12655548 |
| 64 | MP0010094_abnormal_chromosome_stability | 1.11348419 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.08212220 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.06546202 |
| 67 | MP0003448_altered_tumor_morphology | 1.03872715 |
| 68 | MP0000249_abnormal_blood_vessel | 1.01640188 |
| 69 | MP0004883_abnormal_blood_vessel | 0.99836385 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.99188515 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.98651838 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.95780294 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.91869024 |
| 74 | MP0000230_abnormal_systemic_arterial | 0.91696618 |
| 75 | MP0003111_abnormal_nucleus_morphology | 0.90320489 |
| 76 | MP0004084_abnormal_cardiac_muscle | 0.90280927 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.88471538 |
| 78 | MP0008469_abnormal_protein_level | 0.87602617 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.84987715 |
| 80 | MP0008874_decreased_physiological_sensi | 0.84751584 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.80795259 |
| 82 | MP0008058_abnormal_DNA_repair | 0.79936639 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.79329565 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.79206970 |
| 85 | MP0001533_abnormal_skeleton_physiology | 0.78319826 |
| 86 | MP0003787_abnormal_imprinting | 0.77635625 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.75767052 |
| 88 | MP0003693_abnormal_embryo_hatching | 0.74474781 |
| 89 | MP0008872_abnormal_physiological_respon | 0.74110035 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.73185466 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.73169930 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.71631199 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.69134865 |
| 94 | MP0001851_eye_inflammation | 0.69072559 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.68139354 |
| 96 | MP0010307_abnormal_tumor_latency | 0.65851720 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.63331829 |
| 98 | MP0003879_abnormal_hair_cell | 0.62764183 |
| 99 | MP0000350_abnormal_cell_proliferation | 0.62166808 |
| 100 | MP0003045_fibrosis | 0.61943852 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.60774342 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.60666894 |
| 103 | MP0001663_abnormal_digestive_system | 0.60060304 |
| 104 | MP0008775_abnormal_heart_ventricle | 0.59826133 |
| 105 | MP0005410_abnormal_fertilization | 0.59179532 |
| 106 | MP0005451_abnormal_body_composition | 0.59120274 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.58731303 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.57958307 |
| 109 | MP0005023_abnormal_wound_healing | 0.57280137 |
| 110 | MP0002736_abnormal_nociception_after | 0.56306814 |
| 111 | MP0003075_altered_response_to | 0.55729205 |
| 112 | MP0005535_abnormal_body_temperature | 0.55631681 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.55486430 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.55251768 |
| 115 | MP0000313_abnormal_cell_death | 0.54686132 |
| 116 | MP0009764_decreased_sensitivity_to | 0.54406913 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.53891665 |
| 118 | MP0005166_decreased_susceptibility_to | 0.53503897 |
| 119 | MP0004484_altered_response_of | 0.53096502 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.52526824 |
| 121 | MP0005164_abnormal_response_to | 0.51630179 |
| 122 | MP0000609_abnormal_liver_physiology | 0.51203552 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.51148652 |
| 124 | MP0003795_abnormal_bone_structure | 0.46563104 |
| 125 | MP0009763_increased_sensitivity_to | 0.45333175 |
| 126 | MP0001191_abnormal_skin_condition | 0.44787075 |
| 127 | MP0004957_abnormal_blastocyst_morpholog | 0.44487067 |
| 128 | MP0001243_abnormal_dermal_layer | 0.42252163 |
| 129 | MP0009931_abnormal_skin_appearance | 0.40490389 |
| 130 | MP0003091_abnormal_cell_migration | 0.40370187 |
| 131 | MP0005621_abnormal_cell_physiology | 0.40130912 |
| 132 | MP0008770_decreased_survivor_rate | 0.38929918 |
| 133 | MP0002083_premature_death | 0.38329141 |
| 134 | MP0000367_abnormal_coat/_hair | 0.36704567 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.36504630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Menorrhagia (HP:0000132) | 7.74996324 |
| 2 | T lymphocytopenia (HP:0005403) | 7.68517361 |
| 3 | Abnormality of T cell number (HP:0011839) | 7.32534762 |
| 4 | Purpura (HP:0000979) | 6.84537462 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 5.54401569 |
| 6 | Recurrent viral infections (HP:0004429) | 5.36563409 |
| 7 | Abnormality of T cells (HP:0002843) | 5.13188025 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.86575137 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.76298206 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.66483293 |
| 11 | Abnormality of the fingertips (HP:0001211) | 4.66324481 |
| 12 | Combined immunodeficiency (HP:0005387) | 4.60141175 |
| 13 | Impaired platelet aggregation (HP:0003540) | 4.52923426 |
| 14 | Abnormal platelet function (HP:0011869) | 4.52923426 |
| 15 | Chronic otitis media (HP:0000389) | 4.31602353 |
| 16 | IgM deficiency (HP:0002850) | 4.25406661 |
| 17 | Pustule (HP:0200039) | 4.23045133 |
| 18 | Recurrent bronchitis (HP:0002837) | 4.19665687 |
| 19 | B lymphocytopenia (HP:0010976) | 4.19516062 |
| 20 | Abnormality of B cell number (HP:0010975) | 4.19516062 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 4.04347661 |
| 22 | Nasal polyposis (HP:0100582) | 3.95609389 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.92385564 |
| 24 | Eosinophilia (HP:0001880) | 3.91624420 |
| 25 | Thyroiditis (HP:0100646) | 3.88538766 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85328562 |
| 27 | Stomatitis (HP:0010280) | 3.80460734 |
| 28 | IgG deficiency (HP:0004315) | 3.80137759 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.79858721 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.79858721 |
| 31 | Poikilocytosis (HP:0004447) | 3.76322236 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.56921869 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.51201128 |
| 34 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.43443097 |
| 35 | Meningitis (HP:0001287) | 3.41817937 |
| 36 | Granulocytopenia (HP:0001913) | 3.35499441 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.33230817 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.32216332 |
| 39 | Papilloma (HP:0012740) | 3.28348903 |
| 40 | Verrucae (HP:0200043) | 3.28348903 |
| 41 | Acanthocytosis (HP:0001927) | 3.27140345 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 3.24586619 |
| 43 | Myositis (HP:0100614) | 3.21729015 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 3.15634291 |
| 45 | Lymphopenia (HP:0001888) | 3.13790069 |
| 46 | Eczematoid dermatitis (HP:0000976) | 3.06102188 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.03371004 |
| 48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.01234970 |
| 49 | Leukocytosis (HP:0001974) | 2.98446462 |
| 50 | Hypoplasia of the thymus (HP:0000778) | 2.93141944 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.92914395 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.91972100 |
| 53 | Chronic diarrhea (HP:0002028) | 2.86047277 |
| 54 | Conjunctival telangiectasia (HP:0000524) | 2.82563113 |
| 55 | Recurrent sinusitis (HP:0011108) | 2.80582440 |
| 56 | Bruising susceptibility (HP:0000978) | 2.79460015 |
| 57 | Increased IgE level (HP:0003212) | 2.79267469 |
| 58 | Vasculitis (HP:0002633) | 2.78374043 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76029719 |
| 60 | Encephalitis (HP:0002383) | 2.70442034 |
| 61 | Basal cell carcinoma (HP:0002671) | 2.68569619 |
| 62 | Lymphoma (HP:0002665) | 2.66342864 |
| 63 | Joint swelling (HP:0001386) | 2.65593780 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.63348231 |
| 65 | Colitis (HP:0002583) | 2.59504168 |
| 66 | Chronic sinusitis (HP:0011109) | 2.58915927 |
| 67 | Dyschromatopsia (HP:0007641) | 2.57605438 |
| 68 | Abnormal platelet volume (HP:0011876) | 2.51935469 |
| 69 | IgA deficiency (HP:0002720) | 2.51780609 |
| 70 | Recurrent abscess formation (HP:0002722) | 2.51664085 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.50843016 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46881066 |
| 73 | Obstructive lung disease (HP:0006536) | 2.46881066 |
| 74 | Episodic fever (HP:0001954) | 2.44829265 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 2.39320131 |
| 76 | Optic neuritis (HP:0100653) | 2.39320131 |
| 77 | Recurrent skin infections (HP:0001581) | 2.35959266 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.34966208 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.34352923 |
| 80 | Bronchitis (HP:0012387) | 2.30919484 |
| 81 | Cellulitis (HP:0100658) | 2.30192650 |
| 82 | Polycythemia (HP:0001901) | 2.29814060 |
| 83 | Epistaxis (HP:0000421) | 2.28386197 |
| 84 | Abnormal pupillary function (HP:0007686) | 2.28059489 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.26193374 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.24438658 |
| 87 | Hemoptysis (HP:0002105) | 2.21894148 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.20557312 |
| 89 | Paralysis (HP:0003470) | 2.17997702 |
| 90 | Increased IgM level (HP:0003496) | 2.16391688 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14847906 |
| 92 | Hypochromic anemia (HP:0001931) | 2.14327904 |
| 93 | Cheilitis (HP:0100825) | 2.12547192 |
| 94 | Recurrent otitis media (HP:0000403) | 2.09836296 |
| 95 | Abnormality of lateral ventricle (HP:0030047) | 2.08173598 |
| 96 | Increased density of long bones (HP:0006392) | 2.08008703 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 2.07741892 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.05808988 |
| 99 | Increased serum ferritin (HP:0003281) | 2.05247004 |
| 100 | Thrombocytosis (HP:0001894) | 2.02782669 |
| 101 | Recurrent bacterial skin infections (HP:0005406) | 2.00898952 |
| 102 | Gingival bleeding (HP:0000225) | 2.00559838 |
| 103 | Petechiae (HP:0000967) | 2.00170826 |
| 104 | Chest pain (HP:0100749) | 1.99991813 |
| 105 | Emphysema (HP:0002097) | 1.97736047 |
| 106 | Orchitis (HP:0100796) | 1.97344514 |
| 107 | Bronchiectasis (HP:0002110) | 1.95522872 |
| 108 | Gastrointestinal infarctions (HP:0005244) | 1.94871338 |
| 109 | Urticaria (HP:0001025) | 1.94755411 |
| 110 | Tinnitus (HP:0000360) | 1.94712711 |
| 111 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.94356438 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93220675 |
| 113 | Hypergammaglobulinemia (HP:0010702) | 1.92958351 |
| 114 | Acute hepatic failure (HP:0006554) | 1.90514605 |
| 115 | Anorexia (HP:0002039) | 1.90470589 |
| 116 | Ureteral stenosis (HP:0000071) | 1.88772581 |
| 117 | Vertigo (HP:0002321) | 1.88620003 |
| 118 | Increased mean platelet volume (HP:0011877) | 1.85204314 |
| 119 | Periodontitis (HP:0000704) | 1.85114017 |
| 120 | Arterial thrombosis (HP:0004420) | 1.84973030 |
| 121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84797577 |
| 122 | Joint hemorrhage (HP:0005261) | 1.81231584 |
| 123 | Thrombophlebitis (HP:0004418) | 1.80288979 |
| 124 | Skin ulcer (HP:0200042) | 1.79562540 |
| 125 | Prominent nose (HP:0000448) | 1.78952853 |
| 126 | Amaurosis fugax (HP:0100576) | 1.78709317 |
| 127 | Abnormal hair whorl (HP:0010721) | 1.78529305 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.78472789 |
| 129 | Gingivitis (HP:0000230) | 1.77925544 |
| 130 | Microcytic anemia (HP:0001935) | 1.73651863 |
| 131 | Pulmonary embolism (HP:0002204) | 1.73438995 |
| 132 | Abnormality of the prostate (HP:0008775) | 1.72066088 |
| 133 | Bicuspid aortic valve (HP:0001647) | 1.71354546 |
| 134 | Ureteral obstruction (HP:0006000) | 1.71091902 |
| 135 | Sepsis (HP:0100806) | 1.71012559 |
| 136 | Seborrheic dermatitis (HP:0001051) | 1.69862412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.00857259 |
| 2 | TXK | 4.70916111 |
| 3 | ITK | 2.93175262 |
| 4 | GRK6 | 2.89090394 |
| 5 | STK10 | 2.88184578 |
| 6 | JAK3 | 2.80616594 |
| 7 | BMX | 2.77471538 |
| 8 | EEF2K | 2.59195978 |
| 9 | ZAP70 | 2.55080773 |
| 10 | MAP3K10 | 2.49767691 |
| 11 | TAOK3 | 2.48452949 |
| 12 | FGFR4 | 2.39606533 |
| 13 | TYK2 | 2.37440626 |
| 14 | EIF2AK1 | 2.15704722 |
| 15 | MAP3K14 | 1.97085607 |
| 16 | FGFR3 | 1.96197172 |
| 17 | IKBKE | 1.93404444 |
| 18 | CDK12 | 1.88635954 |
| 19 | FGR | 1.82165846 |
| 20 | NLK | 1.81536816 |
| 21 | JAK1 | 1.79330014 |
| 22 | PTK2B | 1.73796542 |
| 23 | BMPR2 | 1.64816595 |
| 24 | SYK | 1.64317013 |
| 25 | SIK2 | 1.62402779 |
| 26 | LCK | 1.60803567 |
| 27 | MAP3K13 | 1.56710757 |
| 28 | BTK | 1.55022539 |
| 29 | PIK3CG | 1.51658635 |
| 30 | TEC | 1.49521438 |
| 31 | MST4 | 1.45465610 |
| 32 | PKN2 | 1.43253500 |
| 33 | MARK3 | 1.42276517 |
| 34 | HCK | 1.41592753 |
| 35 | CSK | 1.40878010 |
| 36 | MYLK | 1.37872566 |
| 37 | PIM1 | 1.30798441 |
| 38 | GRK5 | 1.30620471 |
| 39 | PRKCH | 1.25074940 |
| 40 | TNK2 | 1.23858809 |
| 41 | PRKCQ | 1.18963127 |
| 42 | SIK3 | 1.17816170 |
| 43 | IKBKB | 1.16842120 |
| 44 | MAP3K7 | 1.16743601 |
| 45 | LRRK2 | 1.16632735 |
| 46 | PRPF4B | 1.13047866 |
| 47 | CLK1 | 1.12095068 |
| 48 | BLK | 1.07746343 |
| 49 | TBK1 | 1.03428019 |
| 50 | STK4 | 1.00529979 |
| 51 | TRIB3 | 0.97101071 |
| 52 | MAP3K3 | 0.93023258 |
| 53 | JAK2 | 0.92411542 |
| 54 | IRAK4 | 0.92348933 |
| 55 | TESK2 | 0.92045118 |
| 56 | CAMKK2 | 0.91912934 |
| 57 | CHUK | 0.90528084 |
| 58 | BRD4 | 0.89185120 |
| 59 | CDK4 | 0.87424706 |
| 60 | TAOK2 | 0.83186390 |
| 61 | MAP3K11 | 0.80230058 |
| 62 | MELK | 0.79416581 |
| 63 | MATK | 0.78659713 |
| 64 | PDGFRB | 0.77802820 |
| 65 | TGFBR2 | 0.77486940 |
| 66 | RPS6KA4 | 0.76402020 |
| 67 | SGK3 | 0.75653188 |
| 68 | MAP3K1 | 0.74317754 |
| 69 | CSF1R | 0.74254656 |
| 70 | FES | 0.74133763 |
| 71 | HIPK2 | 0.74046550 |
| 72 | MARK2 | 0.73089840 |
| 73 | PRKD2 | 0.72752018 |
| 74 | LYN | 0.71714317 |
| 75 | EPHB1 | 0.70652496 |
| 76 | PASK | 0.69278250 |
| 77 | KSR2 | 0.68710328 |
| 78 | STK24 | 0.68286814 |
| 79 | CDK9 | 0.67848558 |
| 80 | PAK1 | 0.67604099 |
| 81 | ILK | 0.67364171 |
| 82 | NEK2 | 0.67307159 |
| 83 | FGFR2 | 0.66977012 |
| 84 | EPHA3 | 0.66594199 |
| 85 | MAPK7 | 0.66117268 |
| 86 | FYN | 0.65364301 |
| 87 | MAP2K3 | 0.62474934 |
| 88 | RET | 0.62359463 |
| 89 | MAP3K5 | 0.61937428 |
| 90 | KIT | 0.60578461 |
| 91 | ALK | 0.59583157 |
| 92 | TRPM7 | 0.59112066 |
| 93 | PDPK1 | 0.58470663 |
| 94 | RAF1 | 0.57647237 |
| 95 | YES1 | 0.56898431 |
| 96 | NME2 | 0.56074703 |
| 97 | ADRBK2 | 0.52712665 |
| 98 | TYRO3 | 0.52666072 |
| 99 | STK3 | 0.51399761 |
| 100 | SIK1 | 0.51284667 |
| 101 | CDK6 | 0.50573104 |
| 102 | PDK1 | 0.50093300 |
| 103 | CDC7 | 0.49276152 |
| 104 | TAOK1 | 0.48374166 |
| 105 | FLT3 | 0.48336021 |
| 106 | TTN | 0.44913316 |
| 107 | RPS6KB2 | 0.44824771 |
| 108 | KDR | 0.44551197 |
| 109 | SGK2 | 0.43984651 |
| 110 | MAP3K2 | 0.42139216 |
| 111 | MAPK11 | 0.41656424 |
| 112 | ERBB2 | 0.39417471 |
| 113 | MAPK12 | 0.38707240 |
| 114 | IRAK3 | 0.38505737 |
| 115 | ACVR1B | 0.38478172 |
| 116 | PRKD1 | 0.37178458 |
| 117 | PTK6 | 0.37028552 |
| 118 | NTRK2 | 0.34379485 |
| 119 | RPS6KA6 | 0.33989753 |
| 120 | CAMKK1 | 0.33928662 |
| 121 | ADRBK1 | 0.33854915 |
| 122 | ATR | 0.32915341 |
| 123 | MAPKAPK3 | 0.32878990 |
| 124 | INSR | 0.31055716 |
| 125 | MAPK4 | 0.30483982 |
| 126 | CHEK1 | 0.30463219 |
| 127 | RPS6KA5 | 0.29739065 |
| 128 | IRAK2 | 0.27822486 |
| 129 | MAPK3 | 0.27495809 |
| 130 | RPS6KL1 | 0.27351124 |
| 131 | RPS6KC1 | 0.27351124 |
| 132 | ARAF | 0.26641975 |
| 133 | IRAK1 | 0.26333181 |
| 134 | DYRK1B | 0.25901247 |
| 135 | MAP3K8 | 0.25791439 |
| 136 | CDC42BPA | 0.24986906 |
| 137 | TLK1 | 0.24719573 |
| 138 | DMPK | 0.24395290 |
| 139 | PRKACG | 0.23637178 |
| 140 | RIPK4 | 0.23452367 |
| 141 | MAPKAPK2 | 0.22884190 |
| 142 | KSR1 | 0.22219372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.42236096 |
| 2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.46885614 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71235110 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64220039 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.58478207 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.56670403 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.56113380 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.33125505 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30955335 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21983044 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.21682491 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97891885 |
| 13 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.96111471 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.95165583 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.76630512 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75556349 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.67883122 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65106347 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54063039 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46932905 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46390256 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44151333 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.43740066 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41118604 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39629650 |
| 26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37944300 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35870280 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33032760 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32611611 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30934020 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29879126 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26878364 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.26739559 |
| 34 | HTLV-I infection_Homo sapiens_hsa05166 | 1.22358592 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22232929 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21902053 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18014844 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.17651506 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.14687930 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10029648 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07725712 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05715548 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99931323 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97338466 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.96501057 |
| 46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95287548 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.92530414 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92255013 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91525150 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.90959962 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90246926 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88273032 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88237696 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87813210 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87532433 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85489482 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.85305277 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84326302 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.83730794 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83408506 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81336930 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80883833 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80664481 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79337972 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76698848 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.76388120 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.75892124 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75878478 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.75328491 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.73876231 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73293598 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.72705398 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.72592420 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.72494335 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70702603 |
| 76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65913033 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.64974561 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63350143 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.62465086 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62045181 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61244423 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60522771 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58775205 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58453979 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58269136 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.57990790 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.57522364 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55893089 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55781380 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55567281 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55549841 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55440339 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.54784682 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54535914 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54291564 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54290855 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52136549 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50122048 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49785976 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49352234 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49292116 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49255604 |
| 103 | Cell cycle_Homo sapiens_hsa04110 | 0.49055118 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48961009 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48369048 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48126515 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47130280 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.46957845 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.45819806 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45289992 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44639151 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43398394 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.42764116 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.40324382 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40169450 |
| 116 | Mismatch repair_Homo sapiens_hsa03430 | 0.39876222 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39709368 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.39657105 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39573440 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.39395774 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34224207 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31778112 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30684009 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.30625434 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30032720 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27803822 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27741521 |

